Ligand validation:6A1M

9O9: 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydropyrimido[4,5-b]quinolin-10(2H)-yl)-5-O-phosphono-D-ribitol

9O9 is a Ligand Of Interest in 6A1M designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6A1M_9O9_A_401	81%	11%	0.11	0.963	1.97	2.17	11	17	0	0	100%	1
6A1H_9O9_A_401	96%	23%	0.071	0.981	1.72	1.47	5	8	0	0	100%	1
6A1P_9O9_A_401	88%	18%	0.094	0.968	1.68	1.83	9	11	0	0	100%	1
6A1L_9O9_A_401	81%	13%	0.106	0.957	1.85	2.09	7	12	0	0	100%	1
6I25_9O9_A_404	95%	28%	0.07	0.976	1.47	1.44	5	7	0	0	100%	0.7
6I24_9O9_A_419	90%	30%	0.079	0.962	1.42	1.36	6	6	0	0	100%	0.7
6I23_9O9_A_401	88%	30%	0.093	0.968	1.44	1.35	5	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.